Primary liver cancer presenting as pyogenic liver abscess: Characteristics, diagnosis, and management

2011 ◽  
Vol 105 (7) ◽  
pp. 687-691 ◽  
Author(s):  
Cong Li ◽  
Guangbing Li ◽  
Ruoyu Miao ◽  
Xin Lu ◽  
Shouxian Zhong ◽  
...  
2013 ◽  
Vol 14 (8) ◽  
pp. 4727-4731 ◽  
Author(s):  
Wen-Kuan Huang ◽  
Yung-Chang Lin ◽  
Meng-Jiun Chiou ◽  
Tsai-Sheng Yang ◽  
John Wen-Cheng Chang ◽  
...  

2017 ◽  
Vol 4 (3) ◽  
pp. 1033
Author(s):  
Kong Jun ◽  
Leng Tongmin ◽  
Gong Jianping ◽  
Tang Maoming

Background: Aiming at diagnosing at an early stage, minimizing the misdiagnosis rate and improving the prognosis, the author has investigated the clinical characteristics, diagnosis and treatment of primary liver cancer mimicking liver abscess with a summary and discussion.Methods: All of the 11 cases of primary liver cancer mimicking liver abscess, diagnosed during January 2009 to December 2015, were retrospectively viewed in terms of clinical manifestations, laboratory tests, radiological feature, diagnosis and treatment. And statistic analysis was made in all aspects mentioned above with that of pyogenic liver abscess and other types of liver cancer diagnosed in the corresponding period.  Results: The clinical manifestations of the 11 cases were mostly characterized by fever, abdominal pain and weight loss. There was no significantly statistic difference between the study group and any of the three matched groups in underlying disease and lab results. All of the 11 patients were treated with enhanced antibiotics as basic therapy. Furthermore, eight cases accepted surgical operation, among them, one object underwent puncture and drainage of the liver abscess by ultrasound (PDLA) twice pre-operation, one object underwent PDLA and hepatic arteriography pre-operation and death in hospital post-operation, one object suffered myocardial infarction post-operation. In addition, three cases received conservative treatment only, in which, one object died in hospital.Conclusions: It is difficult to distinguish primary liver cancer mimicking liver abscess from pyogenic liver abscess as there are no specific clinical manifestations and laboratory findings which is prone to leading to misdiagnosis. What’s worse, the prognosis is so poor that high alert and close follow-up are required as well as early diagnosis and treatment. 


Medicine ◽  
2017 ◽  
Vol 96 (34) ◽  
pp. e7785 ◽  
Author(s):  
Chia-Sheng Chu ◽  
Che-Chen Lin ◽  
Cheng-Yuan Peng ◽  
Po-Heng Chuang ◽  
Wen-Pang Su ◽  
...  

2021 ◽  
Vol 4 (1) ◽  
pp. 19-25
Author(s):  
Salem Youssef Mohamed

Hepatocellular carcinoma (HCC) is a heterogeneous disease that develops most of the time on diseases liver. Early diagnosis and management are the best options for the patients, so screening programs are mandatory for those who are at risk of the development of HCC. Despite the challenge of management of HCC, there is hopeful management for HCC as the field of primary liver cancer has moved quickly


1998 ◽  
Vol 26 (5) ◽  
pp. 1224-1226 ◽  
Author(s):  
Ta–Sen Yeh ◽  
Yi–Yin Jan ◽  
Long–Bin Jeng ◽  
Tse–Ching Chen ◽  
Tsang–Long Hwang ◽  
...  

2021 ◽  
Author(s):  
Yiming Liu ◽  
Yanqiao Ren ◽  
Jun Chen ◽  
Songlin Song ◽  
Chuansheng Zheng

Abstract Background: The purpose of this study was to evaluate the clinical, laboratory and microbiological features, clinical outcomes, and prognosis of pyogenic liver abscess (PLA) in non-liver cancer (Non-LC) patients and liver cancer patients treated with transarterial chemoembolization (TACE, LC-TACE).Methods: Clinical data of 48 consecutive PLA patients from January 2016 to December 2020 were retrospectively analyzed. The mortality was compared between the two groups of PLA patients, and risk factors for mortality were evaluated.Results: A total of 48 PLA patients meeting the inclusion criteria were included in this study from January 2016 to December 2020, including 31 males and 17 females. Among them, there were 32 patients in the Non-LC group and 16 patients in the LC-TACE group. Fever and chills were the most common symptoms in both groups, followed by abdominal pain. Shock occurred in 2 patient in the Non-LC group and 3 patients in the LC-TACE group. The positive rate of pus culture in the Non-LC group was 87.5%, among which the most common pathogen was Klebsiella pneumoniae (50%, 14/28), and the positive rate of pus culture in the LC-TACE group was 81.3%, among which the most common pathogen was Escherichia coli (30.8%, 4/13). In the Non-LC group, 28 patients improved after treatment, 1 patient did not improve, and 3 patients died during hospitalization, with a mortality rate of 9.4%. In the LC-TACE group, 9 cases improved after treatment, 3 cases did not improve, and 4 cases died during hospitalization, with a mortality rate of 25%. Multivariate analysis revealed no independent prognostic factor associated with mortality. The cure time of the Non-LC group was 37.4±23.1 days (6-90 days), while that of the LC-TACE group was 91.5±49.7 days (19-180 days), with a statistically significant difference between the two groups (P < 0.001).Conclusions: PLA of the Non-LC group and the LC-TACE group were different in terms of pathogenic bacteria and cure time, etc. For PLA after TACE, a more aggressive and comprehensive treatment should be considered.


1982 ◽  
Vol 69 (1) ◽  
pp. 48-51 ◽  
Author(s):  
J. M. A. Northover ◽  
B. J. M. Jones ◽  
J. L. Dawson ◽  
Roger Williams

Sign in / Sign up

Export Citation Format

Share Document